Asuragen
Manufacturing · Texas, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2150 Woodward St Ste 100, Austin, Texas,...Phone Number
(877) 777-1874Website
www.asuragen.comRevenue
$60.1 MillionIndustry
About Asuragen
Founded in 2006, Asuragen is a global diagnostic products company delivering solutions that build knowledge and understanding of complex clinical questions. Asuragen delivers diagnostic products in oncology and genetics, that provide answers with workflows. From discovery and development to regulatory support to global commercialization, the company also provides a tailored approach that efficiently delivers custom and companion diagnostic products for company partners. The company is headquartered in Austin, Texas.Explore more
Asuragen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Asuragen
Compare insights from companies similar to Asuragen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Asuragen
$60.1M
51-200
Private
$82M
2006
DV
Daniel VummagoniCorporate Development Senior VP & Chief Financial Officer
Asuragen Tech Stack
A closer look at the technologies used by Asuragen
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Asuragen
Sign Up For FreeTo access detailed company insights
Founded in 2006, Asuragen is a global diagnostic products company delivering solutions that build knowledge and understanding of complex clinical questions. Asuragen delivers diagnostic products in oncology and genetics, that provide answers with workflows. From discovery and development to regulatory support to global commercialization, the compan... Read More
